SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-21-008140
Filing Date
2021-04-07
Accepted
2021-04-07 07:35:46
Documents
65

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 1960408
2 ex23-1.htm EX-23.1 4095
3 s-1_001.jpg GRAPHIC 7111
4 img_005.jpg GRAPHIC 122365
5 img_006.jpg GRAPHIC 38429
6 img_003.jpg GRAPHIC 20507
7 img_004.jpg GRAPHIC 17302
  Complete submission text file 0001493152-21-008140.txt   5350992

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ptix-20201231.xml EX-101.INS 600760
9 XBRL SCHEMA FILE ptix-20201231.xsd EX-101.SCH 44035
10 XBRL CALCULATION FILE ptix-20201231_cal.xml EX-101.CAL 52916
11 XBRL DEFINITION FILE ptix-20201231_def.xml EX-101.DEF 201816
12 XBRL LABEL FILE ptix-20201231_lab.xml EX-101.LAB 346153
13 XBRL PRESENTATION FILE ptix-20201231_pre.xml EX-101.PRE 279763
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253006 | Film No.: 21810696
SIC: 7389 Services-Business Services, NEC